Document ID: chunk:federal_register_of_legislation:F2021C00904:reg:9:p5
Version: federal_register_of_legislation:F2021C00904
Segment Type: reg
Provision Reference: reg 9 (pt 5/11)
Character Range: 15923–18937

having infective endocarditis or syphilis involving the coronary arteries at the time of the clinical onset of ischaemic heart disease;
(40)      undergoing a procedure involving catheterisation of the affected coronary artery within the five years before the clinical onset of ischaemic heart disease;
(41)      having an autoimmune disease from the specified list of autoimmune diseases at the time of the clinical onset of ischaemic heart disease;
Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(42)      having gout or hyperuricaemia at the time of the clinical onset of ischaemic heart disease;
Note: hyperuricaemia is defined in the Schedule 1 - Dictionary.
(43)      for angina, acute myocardial infarction or sudden death from ischaemic heart disease only:
(a)          undertaking physical activity of five METs or more within the 24 hours before the clinical onset of ischaemic heart disease;
(b)          experiencing a category 1A stressor within the 48 hours before the clinical onset of ischaemic heart disease;
(c)          experiencing a category 1B stressor within the 48 hours before the clinical onset of ischaemic heart disease;
(d)          experiencing an acute, severe, emotional stressor within the 24 hours before the clinical onset of ischaemic heart disease;
(e)          experiencing the death of a significant other within the 12 months before the clinical onset of ischaemic heart disease;
(f)           using a drug from Specified List 2 of drugs within the 24 hours before the clinical onset of ischaemic heart disease;
(g)          having an episode of acute cholinergic poisoning from exposure to an organophosphorus ester within the seven days before the clinical onset of ischaemic heart disease;
(h)          being exposed to:
(i)            an environment of extreme heat during a heatwave; or
(ii)         an environment of extreme cold during a cold snap; or
(iii)       an abrupt alteration of temperature by ten degrees Celsius or more, to extreme heat or to extreme cold;
             for a period of at least six hours within the seven days before the clinical onset of ischaemic heart disease;
(i)            inhaling ambient highly polluted air as specified for at least two hours within the seven days before the clinical onset of ischaemic heart disease;
(j)            being envenomated by a snake, scorpion, wasp, bee, hornet, spider, fish or jellyfish within the 24 hours before the clinical onset of ischaemic heart disease;
(k)          having an acute hypersensitivity reaction involving the coronary arteries as a result of being exposed to a drug, food or environmental agent from the specified list within the 24 hours before the clinical onset of ischaemic heart disease;
             (ka) having infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the 30 days before the clinical onset of ischaemic heart disease;
(l)            having influenza or a lower respiratory tract infection